PubRank

K Abu-Elmagd

Author PubWeight™ 162.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The many faces of multivisceral transplantation. Surg Gynecol Obstet 1991 6.89
2 Intestinal transplantation in composite visceral grafts or alone. Ann Surg 1992 4.96
3 Replacement of donor lymphoid tissue in small-bowel transplants. Lancet 1991 3.85
4 Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc 1991 3.40
5 Outcome analysis of 71 clinical intestinal transplantations. Ann Surg 1995 2.95
6 Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 2000 2.91
7 Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation 1992 2.75
8 Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc 1991 2.59
9 A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc 1991 2.49
10 Pathology of human intestinal transplantation. Gastroenterology 1996 1.98
11 Logistics and technique for combined hepatic-intestinal retrieval. Ann Surg 1992 1.85
12 The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. Transplantation 1992 1.83
13 Infections in adult liver transplant patients under FK 506 immunosuppression. Transplant Proc 1991 1.75
14 Small intestinal transplantation in humans with or without the colon. Transplantation 1994 1.74
15 Pharmacokinetics of FK 506 following oral administration: a comparison of FK 506 and cyclosporine. Transplant Proc 1991 1.69
16 The question of FK 506 nephrotoxicity after liver transplantation. Transplant Proc 1991 1.60
17 Incidence and risk factors associated with the development of cytomegalovirus disease after intestinal transplantation. Transplantation 1995 1.59
18 Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995 1.59
19 Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation 2000 1.53
20 Morphological monitoring of human small bowel allografts. Transplant Proc 1993 1.52
21 Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation 1992 1.45
22 Intestinal transplantation at the University of Pittsburgh. Transplant Proc 1994 1.42
23 Adverse effects associated with the use of FK 506. Transplant Proc 1991 1.41
24 Abdominal multivisceral transplantation. Transplantation 1995 1.37
25 Neurologic complications of FK 506. Transplant Proc 1991 1.34
26 Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression. Ann Surg 1994 1.33
27 Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. Arch Dermatol 1992 1.32
28 Pharmacokinetics of FK 506 in transplant patients. Transplant Proc 1991 1.30
29 Current status of intestinal transplantation in children. J Pediatr Surg 1998 1.28
30 Infectious complications after small bowel transplantation in adults. Transplant Proc 1994 1.24
31 Clinical small bowel or small bowel plus liver transplantation under FK 506. Transplant Proc 1991 1.24
32 Pharmacokinetics of FK506 in liver transplant recipients after continuous intravenous infusion. J Clin Pharmacol 1993 1.23
33 Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc 1993 1.18
34 Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. Am J Gastroenterol 1995 1.16
35 Disease gravity and urgency of need as guidelines for liver allocation. Hepatology 1994 1.16
36 Factors impacting the survival of children with intestinal failure referred for intestinal transplantation. J Pediatr Surg 1999 1.14
37 Clinical intestinal transplantation: focus on complications. Transplant Proc 1992 1.11
38 Nutritional management of intestinal transplant recipients. Transplant Proc 1993 1.09
39 Graft-versus-host disease after liver and small bowel transplantation in a child. Clin Transplant 1997 1.09
40 Frequent achievement of a drug-free state after orthotopic liver transplantation. Transplant Proc 1993 1.08
41 Cytomegalovirus disease in intestinal transplantation. Transplant Proc 1995 1.07
42 Endoscopy is essential for early detection of rejection in small bowel transplant recipients. Transplant Proc 1994 1.06
43 Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. Am J Gastroenterol 1995 1.05
44 Current status of FK 506 in liver transplantation. Transplant Proc 1991 1.04
45 Bacterial translocation in clinical intestinal transplantation. Transplantation 2001 1.03
46 Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. Transplant Proc 1994 1.03
47 FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh. Springer Semin Immunopathol 1993 1.02
48 Intestinal transplantation in children under FK 506 immunosuppression. J Pediatr Surg 1993 1.02
49 What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients. Ann Surg 1999 1.02
50 Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. Transplant Proc 1996 1.00
51 Perioperative donor bone marrow infusion augments chimerism in heart and lung transplant recipients. Ann Thorac Surg 1995 0.98
52 Resident macrophages are involved in intestinal transplantation-associated inflammation and motoric dysfunction of the graft muscularis. Am J Transplant 2007 0.97
53 Intestinal transplant registry report: global activity and trends. Am J Transplant 2014 0.96
54 Sensorimotor neuropathy resembling CIDP in patients receiving FK506. Muscle Nerve 1994 0.94
55 Factors associated with recurrent cytomegalovirus disease after small bowel transplantation. Transplant Proc 1994 0.94
56 One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. Transplant Proc 1995 0.94
57 Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients. Transplant Proc 1991 0.94
58 Acute invasive sinusitis due to Trichoderma longibrachiatum in a liver and small bowel transplant recipient. Clin Infect Dis 1998 0.93
59 FK 506 versus cyclosporine in pediatric liver transplantation. Transplant Proc 1991 0.93
60 Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. Transplant Proc 1991 0.93
61 Cytomegalovirus infection after intestinal transplantation in children. Clin Infect Dis 1997 0.93
62 Clinical intestinal transplantation. Transplant Proc 1993 0.92
63 Composite liver--small bowel allografts with preservation of donor duodenum and hepatic biliary system in children. J Pediatr Surg 2000 0.92
64 Intrahepatic biliary strictures after liver transplantation. Radiology 1994 0.91
65 Real-time monitoring of acute liver-allograft rejection using the Banff schema. Transplantation 2002 0.91
66 Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506. Transplant Proc 1993 0.90
67 Intestinal transplantation in humans under FK 506. Transplant Proc 1993 0.90
68 Donor selection and surgical technique for en bloc liver-small bowel graft procurement. Transplant Proc 1993 0.90
69 Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc 1996 0.90
70 Analysis of patients with longitudinal intestinal lengthening procedure referred for intestinal transplantation. J Pediatr Surg 2001 0.90
71 Reduced-size orthotopic composite liver-intestinal allograft. Transplantation 1998 0.89
72 FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. Transplant Proc 1991 0.89
73 Quality of life after small intestinal transplantation and among home parenteral nutrition patients. JPEN J Parenter Enteral Nutr 1999 0.88
74 Endorectal pull-through of transplanted colon as part of intestinal transplantation. Surgery 1995 0.88
75 Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. Transplant Proc 1992 0.87
76 EBV-specific CD8+ T cell reactivation in transplant patients results in expansion of CD8+ type-1 regulatory T cells. Am J Transplant 2007 0.87
77 Adjuvant bone marrow infusion in clinical organ transplant recipients. Transplant Proc 1998 0.86
78 Immunomodulation of intestinal transplant with allograft irradiation and simultaneous donor bone marrow infusion. Transplant Proc 1999 0.86
79 Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J Leukoc Biol 1999 0.85
80 Biliary strictures in hepatic transplants: prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases. AJR Am J Roentgenol 1993 0.84
81 Bacterial translocation in clinical intestinal transplantation. Transplant Proc 2000 0.83
82 Perioperative infliximab application has marginal effects on ischemia-reperfusion injury in experimental small bowel transplantation in rats. Langenbecks Arch Surg 2011 0.83
83 Clinical and endoscopic features of rejection in small bowel transplant recipients. Transplant Proc 1994 0.83
84 Quality of life of patients after intestinal transplantation. Transplantation 1998 0.83
85 Infectious complications after human small bowel transplantation. Transplant Proc 1992 0.82
86 Quality of life after intestinal transplantation and on total parenteral nutrition. Transplant Proc 1998 0.82
87 The impact of positive T-cell lymphocytotoxic crossmatch on intestinal allograft rejection and survival. Transplant Proc 2000 0.82
88 Use of DNA amplification for diagnosis of cytomegalovirus enteritis after intestinal transplantation. Gastroenterology 1997 0.82
89 Contrast examination of the small bowel in patients with small-bowel transplants: findings in 16 patients. AJR Am J Roentgenol 1993 0.81
90 Histologic monitoring of human small bowel allografts with clinical correlation. Transplant Proc 1992 0.81
91 Hepatic transplantation during pregnancy and the puerperium. J Matern Fetal Med 1997 0.81
92 Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine. Transplant Proc 1993 0.81
93 Bacteremia after intestinal transplantation in children correlates temporally with rejection or gastrointestinal lymphoproliferative disease. Transplantation 2000 0.80
94 Autoimmune liver diseases. Recurrence after liver transplantation. Surg Clin North Am 1999 0.80
95 Infectious complications after small bowel transplantation in adults: an update. Transplant Proc 1996 0.80
96 Intestinal transplantation in children after primary liver transplantation. Transplant Proc 1998 0.80
97 FK 506 used as rescue therapy for human liver allograft recipients. Transplant Proc 1991 0.80
98 Late severe rejection of intestinal allografts: risks and survival outcome. Transplant Proc 2001 0.80
99 Rituximab in the treatment of pediatric small bowel transplant patients with posttransplant lymphoproliferative disorder unresponsive to standard treatment. Transplant Proc 2002 0.79
100 Perioperative infliximab application ameliorates acute rejection associated inflammation after intestinal transplantation. Am J Transplant 2010 0.79
101 Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection. Transplant Proc 1991 0.79
102 Prospective evaluation of endoscopy in acute cellular rejection and cytomegalovirus infection. Transplant Proc 1996 0.79
103 Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation. Transplant Proc 1992 0.79
104 Lymphocyte trafficking using in situ hybridization and physioanatomy of the intestinal immune system after human small bowel transplantation. Transplant Proc 1992 0.78
105 Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients. Transplantation 1992 0.78
106 Influence of FK 506 on T lymphocytes, Langerhans' cells and the expression of cytokine receptors and adhesion molecules in psoriatic skin lesions: a preliminary study. Transplant Proc 1991 0.78
107 Intestinal transplantation for patients with short gut syndrome and hypercoagulable states. Transplant Proc 2000 0.78
108 Posttransplant lymphoproliferative disorders in small bowel allograft recipients. Transplant Proc 2000 0.78
109 Current status of intestinal transplantation. Adv Surg 1994 0.78
110 Management of portal hypertension-related bleeding. Surg Clin North Am 1999 0.78
111 Skeletal integrity and visceral transplantation. Am J Transplant 2010 0.77
112 Candidates for intestinal transplantation and possible indicators of outcome. Transplant Proc 1994 0.77
113 Hospitalization and readmission of intestinal transplantation recipients. Transplant Proc 1994 0.77
114 Influence of immunosuppression on alloresponse, inflammation and contractile function of graft after intestinal transplantation. Am J Transplant 2010 0.77
115 Intestinal transplantation: 4-year experience. Transplant Proc 1995 0.77
116 Evolution of surgical techniques in clinical intestinal transplantation. Transplant Proc 1994 0.77
117 Intestinal regeneration, residual function and immunological priming following rescue therapy after rat small bowel transplantation. Am J Transplant 2012 0.77
118 Central venous thrombosis and perioperative vascular access in adult intestinal transplantation. Br J Anaesth 2012 0.77
119 Incidence of CD4+ IL-2R alpha+ and CD4+ CD45RA+ T-cells in progressive multiple sclerosis and the influence of short-term (3 months) FK 506 therapy. Ann N Y Acad Sci 1993 0.77
120 Overview of FK506 in transplantation. Clin Transpl 1990 0.76
121 Isolated intestinal versus composite visceral allografts: causes of graft failure. Transplant Proc 2000 0.76
122 Bronchiolitis obliterans organizing pneumonia in a BMT patient receiving FK506. Bone Marrow Transplant 1993 0.76
123 Variability in the interpretations of endoscopic findings in patients with intestinal transplantation. Transplant Proc 1996 0.75
124 Immune modulation in organ allograft recipients by single or multiple donor bone marrow infusions. Transplant Proc 1999 0.75
125 Effect of CMV serology on outcome after clinical intestinal transplantation. Transplant Proc 1996 0.75
126 Long-term function and morphology of intestinal allografts in outbred canine transplantation model. Transplant Proc 2002 0.75
127 Donor bone marrow infusion in liver recipients: effect on the occurrence of acute cellular rejection. Transplant Proc 2001 0.75
128 In-vitro interaction of a novel immunosuppressant, FK 506, and antacids. J Pharm Pharmacol 1991 0.75
129 Influence of donor criteria on early outcome after intestinal transplantation. Transplant Proc 1997 0.75
130 The use of FK 506 in new-onset type I diabetes in man. Transplant Proc 1991 0.75
131 Immunoreactivity of T lymphocytes propagated from biopsies of human cadaveric small intestine allografts: a serial study of four patients. Transplant Proc 1992 0.75
132 Nutritional management of intestinal allograft recipients. Transplant Proc 1998 0.75
133 Metabolic effects of FK 506 in patients with severe psoriasis: short-term follow-up of seven cases. Transplant Proc 1991 0.75
134 FK 506 in small bowel transplant recipients: pharmacokinetics and dosing. Transplant Proc 1994 0.75
135 The long-term efficacy of multivisceral transplantation. Transplant Proc 2000 0.75
136 Immunodulation of intestinal transplantation: antilymphocyte serum donor pretreatment vs. ex vivo graft irradiation. Transplant Proc 2002 0.75
137 Use of the D-xylose absorption test in monitoring intestinal allografts. Transplant Proc 1994 0.75
138 Intestinal transplantation at the University of Pittsburgh: six-year experience. Transplant Proc 1997 0.75
139 Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506. Transplant Proc 1991 0.75
140 Functional analysis of graft lamina propria associated lymphocytes from a recipient of a human cadaveric small bowel allograft primarily immunosuppressed with FK 506. Transplant Proc 1991 0.75
141 Intestinal transplantation in 31 adults. Transplant Proc 1996 0.75
142 In vitro assessment of FK 506 immunosuppressive activity in transplant patients. Transplant Proc 1991 0.75
143 Influence of FK 506 (tacrolimus) on circulating CD4+ T cells expressing CD25 and CD45RA antigens in 19 patients with chronic progressive multiple sclerosis participating in an open label drug safety trial. Autoimmunity 1994 0.75
144 CMV infection in liver transplantation under cyclosporine or FK 506 immunosuppression. Transplant Proc 1991 0.75
145 Abnormal gastric emptying after intestinal transplantation. Transplant Proc 1994 0.75
146 Basic considerations for the procurement of intestinal grafts. Transplant Proc 1994 0.75
147 Liver allograft pathology in liver/small bowel or multivisceral recipients. Mod Pathol 1996 0.75
148 Patient profile and candidacy for intestinal transplantation at the University of Pittsburgh. Transplant Proc 2002 0.75
149 Nutritional monitoring of pediatric intestinal transplant recipients. Transplant Proc 1998 0.75
150 Clinical intestinal transplantation. Clin Nutr 1996 0.75
151 [Clinical experience with FK 506]. Presse Med 1991 0.75
152 Long-term nutritional monitoring after clinical intestinal transplantation. Transplant Proc 1998 0.75
153 Early clinical and histologic viability of human liver-small intestinal allografts after implantation. Clin Transplant 1994 0.75
154 Sterilization of human small intestine allograft biopsies for later immunologic studies. Transplantation 1991 0.75
155 Endoscopic features of acute cellular rejection. Transplant Proc 1996 0.75
156 Psychiatric evaluations of small intestine transplantation patients. Gen Hosp Psychiatry 1996 0.75
157 The neuropathology of intestinal failure and small bowel transplantation. Acta Neuropathol 1999 0.75
158 Intestinal and multivisceral transplantation. Radiol Clin North Am 1995 0.75
159 Liver allograft pathology in liver/small bowel or multivisceral recipients. Transplant Proc 1996 0.75
160 The latest advances in liver transplantation at the pittsburgh transplantation institute: evolution of FK506, liver-intestinal transplantation, clinical xenotransplantation, and the induction of graft acceptance. Surg Technol Int 1994 0.75
161 Combined intestine and kidney transplantation in a patient with encapsulating peritoneal sclerosis: case report. Am J Transplant 2013 0.75
162 A clinicopathologic study of isolated intestinal allografts with preformed IgG lymphocytotoxic antibodies. Transplant Proc 2002 0.75
163 Intestinal transplantation with or without other abdominal organs: nutritional and dietary management of 50 patients. Transplant Proc 1994 0.75
164 Histologic spectrum of acute cellular rejection in human intestinal allografts. Transplant Proc 1996 0.75